CompletedNCT03033732
A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
Medication studyAges 18–64CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Calgary and 6 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 2, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 272
- Sponsor
- Didier Jutras Aswad
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT03033732
- Official title
Show the full official title
Optimizing Patient Centered-Care: A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA Trial)
Recruitment & locations
CompletedCalgary · Edmonton · Vancouver
3 more locations
- Greater Sudbury
- Toronto
- Montreal
Questions about this study
Who is behind this study?
The study sponsor is Didier Jutras Aswad.
Did this study involve medication?
Yes. The study involved medication, including Methadone and Buprenorphine-Naloxone.
Who was this study for?
Listed age limits: 18 years to 64 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me